Bridges to Better Medicine - Home - The Rockefeller University

Welcome

Bridges to Better Medicine brings together world class scientists and business leaders in the life sciences - venture capitalists, biotechnology and pharmaceutical executives, healthcare investors and analysts. The Rockefeller University believes that fostering a robust intellectual exchange between academia and industry is critical to advancing biomedical breakthroughs.

Bridges offers you opportunities to:

hear about the latest scientific and medical innovations from inside the lab and from industry;
interact with top scientists and industry leaders in a private setting;
develop valuable relationships and exchange ideas with peers.

Through this program, The Rockefeller University hopes to develop friendships and inspire philanthropy among individuals in life science-related businesses.

Upcoming Events

Please check back soon for more information about upcoming events.

Past Events

If you have questions, or would like to make suggestions for future programs, please call (212) 327-8910 or email bridges@rockefeller.edu.

News

November 28, 2012
Robert Darnell named president of New York Genome Center
Robert B. Darnell, Robert and Harriet Heilbrunn Professor and head of the Laboratory of Molecular Neuro-oncology, will direct all aspects of the NYGC, including its scientific and research activities, and the recruitment and development of a world-class scientific team in genomic research and medicine.

September 4,2012
Vitamin D supplements do not improve cholesterol as previous research suggested
Vitamin D has been touted for its beneficial effects on a range of human systems. But it does not improve cholesterol levels, according to a new study conducted at The Rockefeller University Hospital.

August 10, 2012
Protein proves vital in immune response to bacteria
Scientists have discovered that a protein once thought to be mainly involved in antiviral immunity is in fact more important in fighting bacterial infections.

May 24, 2012
Rockefeller creates Cohn-Steinman Professorship to honor discoverers of dendritic cells
The family of the late Ralph Steinman, who died three days before winning the Nobel Prize, will donate much of the proceeds from the award to establish the Cohn-Steinman Professorship at Rockefeller. The professorship will create an enduring memorial to Steinman and his mentor and collaborator, Zanvil Cohn.

April 20, 2012
Rockefeller creates Cohn-Steinman Professorship to honor discoverers of dendritic cells
The family of the late Ralph Steinman, who died three days before winning the Nobel Prize, will donate much of the proceeds from the award to establish the Cohn-Steinman Professorship at Rockefeller. The professorship will create an enduring memorial to Steinman and his mentor and collaborator, Zanvil Cohn.

March 21, 2012
Albany Medical Center Prize awarded to James E. Darnell, Jr. and Robert G. Roeder
Darnell and Roeder are being recognized for helping to define how cells grow, replicate, and become specialized, and in turn giving medical professionals and researchers the tools to improve health and combat diseases.

February 27, 2012
$15 million gift from Helmsley Trust to fund research on digestive diseases
Funds will establish a new center, to be known as the Center for Basic and Translational Research on Disorders of the Digestive System, which will support interdisciplinary basic research and foster collaborations among some 20 Rockefeller labs.

December 16, 2011
In cancer, molecular signals that recruit blood vessels also trigger metastasis
Cancer cells are most deadly when they’re on the move. New research has now shown how a miRNA prevents the recruitment and formation of blood vessels near cancer cells destined to become metastases.

November 17, 2011
Statin-intolerant patients need a different type of clinical trial
Although only 5% of people in clinical trials report side effects from statin drugs, in practice the problem is far greater. Clinical trials need to better address the needs of statin-intolerant patients, Rockefeller researchers say.

The Rockefeller University gratefully acknowledges the generous support of:

Marc Tessier-Lavigne, Ph.D.
President
The Rockefeller University

Moderator

Barry Coller, M.D.
Vice President for Medical Affairs and Physician-in-Chief
The Rockefeller University

Director
Center for Clinical and Translational Science

Co-Chairs

Anthony B. Evnin, Ph.D.
General Partner
Venrock

Robin Chemers Neustein
Senior Director
Goldman, Sachs & Co.

Steering Committee

Ron Cohen, M.D.
Acorda Therapeutics

Kathleen Denis, Ph.D.
The Rockefeller University

David Elliman
Elmrock Capital

Emilio Emini, Ph.D.
Pfizer

Teena Lerner, Ph.D.
Rx Capital Management

Paul Maddon, M.D., Ph.D.
Progenics Pharmaceuticals

Brad Margus
Envoy Therapeutics

Sharon Mates, Ph.D.
Intra-Cellular Therapies

Robin Chemers Neustein
Goldman, Sachs & Co.

Russell Pennoyer
Benedetto, Gartland & Co.

Geoff Smith
Ascent Biomedical Ventures

George Yancopoulos, M.D., Ph.D.
Regeneron Pharmaceuticals

bridges@rockefeller.edu